New Issue: Envision Healthcare prices upsized $750 million 5 1/8% eight-year notes at par

By Paul A. Harris

Portland, Ore., June 12 – Envision Healthcare Corp. priced an upsized $750 million issue of eight-year senior notes (B3/B/) at par to yield 5 1/8% on Thursday, according to a syndicate source.

The quick-to-market deal was upsized from $650 million.

The yield printed on top of yield talk.

Barclays was the lead left bookrunner. BofA Merrill Lynch, Deutsche Bank Securities Inc., Goldman Sachs & Co., Citigroup Global Markets Inc., Jefferies LLC, Morgan Stanley & Co. LLC, Natixis Securities Americas LLC, RBC Capital Markets LLC and UBS Securities LLC were the joint bookrunners.

The Greenwood Village, Colo.-based health care services provider plans to redeem its 8 1/8% senior notes due 2019.

Issuer:	Envision Healthcare Corp.
Amount:	$750 million, increased from $650 million
Maturity:	July 1, 2022
Securities:	Senior notes
Left bookrunner:	Barclays
Joint bookrunners:	BofA Merrill Lynch, Deutsche Bank Securities Inc., Goldman Sachs & Co., Citigroup Global Markets Inc., Jefferies LLC, Morgan Stanley & Co. LLC, Natixis Securities Americas LLC, RBC Capital Markets LLC, UBS Securities LLC
Coupon:	5 1/8%
Price:	Par
Yield:	5 1/8%
Spread:	271 bps
First call:	July 1, 2017 at 103.844
Trade date:	June 12
Settlement date:	June 18
Ratings:	Moody's: B3
	Standard & Poor's: B
Distribution:	Rule 144A and Regulation S for life
Price talk:	5 1/8%
Marketing:	Quick to market

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.